[1] 邱琰. 放射性核素防护病房的建立与护理管理[J]. 上海护理,2011,11(6):80-81. DOI: 10.3969/j.issn.1009-8399.2011.06.030 Qiu Y. Establishment and nursing management of radionuclide protection ward[J]. Shanghai Nurs J, 2011, 11(6): 80-81. DOI: 10.3969/j.issn.1009-8399.2011.06.030 [2] 刘丽娜, 刘斌, 黄蕤, 等. 核医学诊疗的辐射防护与安全[J]. 中国医学影像技术,2017,33(12):1888-1892. DOI: 10.13929/j.1003-3289.201707009 Liu LN, Liu B, Huang R, et al. Radiation protection and safety in nuclear medicine[J]. Chin J Med Imaging Technol, 2017, 33(12): 1888-1892. DOI: 10.13929/j.1003-3289.201707009 [3] 彭亮, 李长越, 孟丹, 等. 分化型甲状腺癌术后放射性131 I治疗对育龄期人群生育力影响研究[J]. 临床军医杂志,2020,48(9):1099-1100. DOI: 10.16680/j.1671-3826.2020.09.39 Peng L, Li CY, Meng D, et al. Study on the effect of postoperative radioactive 131 I treatment for differentiated thyroid cancer on fertility in people of reproductive age[J]. Clinical J Med Officer, 2020, 48(9): 1099-1100. DOI: 10.16680/j.1671-3826.2020.09.39 [4] 朱卫国, 侯长松, 佟鹏, 等. 我国五省核医学工作场所放射性核素浓度分析[J]. 中国辐射卫生,2020,29(3):249-252. DOI: 10.13491/j.issn.1004-714X.2020.03.012 Zhu WG, Hou CS, Tong P, et al. Analysis of radionuclide concentration in workplaces of nuclear medicine in five provinces of China[J]. Chin J Radiol Health, 2020, 29(3): 249-252. DOI: 10.13491/j.issn.1004-714X.2020.03.012 [5] 王洁, 张涵宇, 邬家龙, 等. 甘肃省3家医院核医学科放射工作人员内照射水平分析[J]. 中国辐射卫生,2020,29(4):357-361. DOI: 10.13491/j.issn.1004-714X.2020.04.009 Wang J, Zhang HY, Wu JL, et al. Analysis of radiation internal exposure in nuclear medicine staff of three hospitals in Gansu Province[J]. Chin J Radiol Health, 2020, 29(4): 357-361. DOI: 10.13491/j.issn.1004-714X.2020.04.009 [6] 中华人民共和国国家卫生健康委员会. GBZ 120—2020 核医学放射防护要求[S]. 北京: 中国标准出版社, 2020. National Health Commission of People’s Republic of China. GBZ 120—2020 Requirements for radiological protection in nuclear medicine[S]. Beijing: Standards Press of China, 2020. [7] 赵尧贤, 吴寿明, 宣志强, 等. 放射性核素治疗工作场所设计及放射防护措施评价分析[J]. 中国辐射卫生,2010,19(4):420-421. DOI: 10.13491/j.cnki.issn.1004-714X.2010.04.012 Zhao YX, Wu SM, Xuan ZQ, et al. Radionuclide treatment workplace design and radiological protection measures evaluation analysis[J]. Chin J Radiol Health, 2010, 19(4): 420-421. DOI: 10.13491/j.cnki.issn.1004-714X.2010.04.012 [8] 巴建涛, 付海鸿, 吕京桥, 等. ~(131)I治疗病房的辐射防护设计[J]. 中华放射医学与防护杂志,2009,29(6):614-617. DOI: 10.3760/cma.j.issn.0254-5098.2009.06.018 Ba JT, Fu HH, Lv JQ, et al. Radiation shielding of ~(131)I therapeutic ward in department[J]. Chin J Radiol Med Prot, 2009, 29(6): 614-617. DOI: 10.3760/cma.j.issn.0254-5098.2009.06.018 [9] Yonekura Y, Mattsson S, Flux G, et al. ICRP publication 140: radiological protection in therapy with radiopharmaceuticals[J]. Ann ICRP, 2019, 48(1): 5-95. DOI: 10.1177/0146645319838665 [10] International Commission on Radiological Protection. Release of patients after therapy with unsealed radionuclides[J]. Ann ICRP, 2004, 34(2): v-vi,1-79. DOI: 10.1016/j.icrp.2004.08.001 [11] Cho SG, Kim J, Song HC. Radiation safety in nuclear medicine procedures[J]. Nucl Med Mol Imaging, 2017, 51(1): 11-16. DOI: 10.1007/s13139-016-0406-0 [12] 中华人民共和国国家质量监督检验检疫总局. GB 18871—2002 电离辐射防护与辐射源安全基本标准[S]. 北京: 中国标准出版社, 2003. General Administration of Quality Supervision, Inspection and Quarantine of the People’s Republic of China. GB 18871—2002 Basic standards for protection against ionizing radiation and for the safety of radiation sources [S]. Beijing: Standards Press of China, 2003. [13] 杨福洲, 李车琼, 李毅. 分化型甲癌患者131碘治疗后体外辐射水平的研究[J]. 黑龙江医药,2016,29(3):409-412. DOI: 10.14035/j.cnki.hljyy.2016.03.011 Yang FZ, Li CQ, Li Y. Radiation levels in vitro study of differentiated thyroid cancer treated by 131 iodine radioactive isotopes[J]. Heilongjiang Med J, 2016, 29(3): 409-412. DOI: 10.14035/j.cnki.hljyy.2016.03.011 [14] 赵海敏, 杨金兰, 张桂清. 临床核医学治疗中131Ⅰ所致辐射剂量的研究[J]. 中国辐射卫生,2010,19(4):487-488. DOI: 10.13491/j.cnki.issn.1004-714X.2010.04.024 Zhao HM, Yang JL, Zhang GQ. Study on radiation dose caused by 131I in clinical nuclear medicine treatment[J]. Chin J Radiol Health, 2010, 19(4): 487-488. DOI: 10.13491/j.cnki.issn.1004-714X.2010.04.024 [15] 中华人民共和国卫生部. GBZ 133—2009 医用放射性废物的卫生防护管理[S]. 北京: 人民卫生出版社, 2010. Ministry of Health of the People's Republic of China. GBZ 133—2009 Radiological protection management for medical radioactive waste[S]. Beijing: People’s Medical Publishing House, 2010. [16] 国家环境保护总局. GB 18466—2005 医疗机构水污染物排放标准[S]. 北京: 中国环境科学出版社, 2005. State Environmental Protection Administration. GB 18466—2005 Discharge standard of water pollutants for medical organization[S]. Beijing: China Environment Science Press, 2005. [17] 陈飞, 张震, 王雪涛, 等. 水中总α和总β放射性分析的质量控制[J]. 中华放射医学与防护杂志,2020,40(8):618-622. DOI: 10.3760/cma.j.issn.0254-5098.2020.08.008 Chen F, Zhang Z, Wang XT, et al. Quality control of gross α and gross β analysis in water[J]. Chin J Radiol Med Prot, 2020, 40(8): 618-622. DOI: 10.3760/cma.j.issn.0254-5098.2020.08.008 [18] 胡建伟, 戴瑜. 从环评及检测角度探讨放射性衰变池设置[J]. 中国辐射卫生,2017,26(4):439-442. DOI: 10.3969/j.issn.1004-714X.2017.04.020 Hu JW, Dai Y. Discussion on the setting of radioactive decay pool from the perspective of environmental assessment and detection[J]. Chin J Radiol Health, 2017, 26(4): 439-442. DOI: 10.3969/j.issn.1004-714X.2017.04.020